Orthopedic Bone Cement and Casting Materials Market By Product Type (Bone Cement, Casting Materials), By Application (Joint Replacement, Fracture Repair, Spinal Fusion Procedures), By End-User (Hospitals, Orthopedic Clinics, Rehabilitation Centers), and By Region; Global Insights & Forecast (2023 – 2030)

As per Intent Market Research, the Orthopedic Bone Cement and Casting Materials Market was valued at USD 1.5 billion in 2024-e and will surpass USD 2.5 billion by 2030; growing at a CAGR of 8.9% during 2025 - 2030.

The orthopedic bone cement and casting materials market is experiencing significant growth as the demand for orthopedic surgeries continues to rise globally. Bone cement is primarily used to anchor prostheses to bone surfaces during joint replacement surgeries, while casting materials are essential for immobilizing fractures during the healing process. As musculoskeletal disorders, such as osteoarthritis and fractures, become more prevalent, particularly among aging populations, the need for effective treatments involving bone cement and casting materials is expanding. This market growth is further driven by advancements in material formulations that improve the strength, durability, and biocompatibility of these products.

Technological innovations, such as the development of bone cements with faster curing times, enhanced mechanical properties, and antimicrobial properties, are also contributing to the market's expansion. Casting materials, which include both traditional plaster and more advanced synthetic materials like fiberglass, are evolving to offer lighter, more durable, and comfortable solutions for patients undergoing fracture repair. As a result, orthopedic surgeons now have access to a wider variety of materials that allow for better patient outcomes and improved surgical efficiency. This growing availability of high-quality orthopedic materials is anticipated to drive further market growth.

Bone Cement Is Largest Product Type Segment Owing to Its Crucial Role in Joint Replacement Surgeries

Bone cement is the largest product type segment in the orthopedic bone cement and casting materials market, primarily due to its critical role in joint replacement surgeries, such as hip and knee replacements. Bone cement is used to anchor prosthetic devices to the surrounding bone, ensuring the stability and longevity of the joint implant. This cement is essential in orthopedic surgeries where patients have damaged or weakened bones due to conditions such as arthritis, fractures, or osteoporosis. The growing number of joint replacement procedures, fueled by the aging population and increasing prevalence of degenerative bone diseases, is driving the demand for bone cement.

The demand for bone cement is also bolstered by ongoing innovations in cement formulations. For instance, the development of low-viscosity bone cement has enhanced the ease of application and reduced the potential for complications during surgeries. Additionally, the addition of antibiotics to bone cement formulations is improving outcomes by preventing post-surgical infections. As joint replacement surgeries become more common and the need for durable, reliable fixation materials increases, bone cement remains the dominant product type in the orthopedic market.

Fracture Repair Is Fastest-Growing Application Segment Owing to Rising Incidence of Bone Fractures

Fracture repair is the fastest-growing application segment in the orthopedic bone cement and casting materials market, driven by the increasing incidence of bone fractures, particularly in elderly populations. The global aging population is more prone to fractures due to conditions like osteoporosis, which weakens bones and increases the risk of fractures. Moreover, lifestyle-related factors, such as high-impact sports, accidents, and falls, contribute to the growing need for fracture repair materials. Casting materials are crucial in the management and stabilization of fractures during the healing process, allowing the bones to mend properly.

Innovations in casting materials, such as the development of lightweight, breathable, and stronger fiberglass-based casts, are further driving the growth of the fracture repair segment. These materials offer improved patient comfort and can be molded to provide better immobilization and support during the healing process. As the global incidence of bone fractures continues to rise, particularly among older adults, the demand for fracture repair solutions, including bone cement for internal stabilization and casting materials for external immobilization, is expected to accelerate.

Hospitals Are Largest End-User Segment Due to High Volume of Surgeries

Hospitals are the largest end-user segment in the orthopedic bone cement and casting materials market, as they perform a high volume of joint replacement surgeries, fracture repairs, and spinal fusion procedures. Hospitals, with their comprehensive surgical and rehabilitation facilities, are the primary setting for orthopedic procedures that require both bone cement and casting materials. The wide variety of orthopedic surgeries conducted in hospitals, including hip, knee, and shoulder replacements, as well as fracture management and spinal surgeries, necessitates the use of advanced materials to ensure optimal surgical outcomes and patient recovery.

In addition to the high surgical volume, hospitals are often the first to adopt the latest advancements in orthopedic materials due to their access to specialized surgical teams and equipment. As the prevalence of orthopedic conditions continues to rise globally, hospitals are expected to maintain their position as the largest consumers of bone cement and casting materials. The growing demand for joint replacements, fracture repairs, and spinal surgeries is expected to drive the continued dominance of hospitals in this market segment.

North America Is Largest Region Owing to Advanced Healthcare Infrastructure and High Surgical Volume

North America is the largest region in the orthopedic bone cement and casting materials market, driven by its advanced healthcare infrastructure, high surgical volume, and increasing number of orthopedic procedures. The United States, in particular, represents a significant portion of the market due to the high prevalence of musculoskeletal disorders, such as osteoarthritis, fractures, and spinal conditions, which require orthopedic interventions. North America's well-established healthcare systems, coupled with the availability of cutting-edge surgical technologies and skilled orthopedic surgeons, contribute to its dominant position in the market.

The growing aging population in North America, combined with a high rate of sports-related injuries and accidents, is driving the demand for bone cement and casting materials. Furthermore, hospitals and orthopedic clinics in the region are at the forefront of adopting new materials and techniques in orthopedic surgery, contributing to the continued growth of the market. As the demand for joint replacement surgeries and fracture repair procedures increases, North America is expected to maintain its position as the largest regional market for orthopedic bone cement and casting materials.

Competitive Landscape: Leading Companies and Market Trends

The orthopedic bone cement and casting materials market is highly competitive, with key players such as Stryker Corporation, Zimmer Biomet, DePuy Synthes (Johnson & Johnson), and Smith & Nephew leading the market. These companies offer a wide range of bone cement and casting materials, including products designed for joint replacement surgeries, fracture repairs, and spinal fusion procedures. The competitive landscape is shaped by ongoing innovations in material formulations, with companies focusing on developing bone cements that offer faster curing times, enhanced mechanical properties, and better biocompatibility.

In addition to the major players, several smaller companies are entering the market with specialized products targeting specific orthopedic applications. For instance, some companies are focusing on developing biodegradable bone cement formulations, which can be absorbed by the body over time, eliminating the need for additional surgeries to remove the cement. The market is also witnessing a trend toward the integration of advanced casting materials, such as fiberglass-based casts, which offer superior comfort, durability, and patient compliance compared to traditional plaster casts. As competition intensifies, companies are focusing on product innovation, strategic partnerships, and expanding their distribution networks to maintain a competitive edge.

Recent Developments:

• In January 2023, Stryker Corporation launched a new advanced bone cement formulation designed to improve joint replacement surgery outcomes.
• In February 2023, Medtronic introduced an innovative bioactive bone cement for spinal fusion procedures, showing enhanced biocompatibility.
• In March 2023, Zimmer Biomet received FDA approval for a new calcium phosphate cement designed for faster fracture healing.
• In April 2023, DePuy Synthes (Johnson & Johnson) unveiled a new synthetic casting material offering better flexibility and comfort for patients.
• In May 2023, Smith & Nephew announced the acquisition of a leading bone cement technology company to expand its product range in orthopedic surgeries.

List of Leading Companies:

• Stryker Corporation
• Zimmer Biomet
• Johnson & Johnson Medical
• Medtronic
• Smith & Nephew
• DePuy Synthes (Johnson & Johnson)
• Wright Medical
• Aesculap
• Orthofix Medical
• B. Braun Melsungen
• DJO Global
• Exactech
• Biomet
• 3M
• Heraeus Medical

Report Scope: